# A Randomized, Two-arm, Open Label Study to evalUate the Effect of a Smart Phone-based Patient Support Tool On Patient AdheRence of Treatment in Stable Angina Patients Prescribed Beta-blockers in China (SUPPORT)

Study · id `cardio:ct-nct03794713` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03794713](<https://clinicaltrials.gov/study/NCT03794713>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03794713

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 432 participants.

## Technical summary

Registry record NCT03794713. Randomized; no masking; primary purpose treatment. Start 2019-04-01 (anticipated); primary completion 2020-09-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 432 participants (planned count; ClinicalTrials.gov record NCT03794713, source copy `cardio:ctgov-nct03794713-2019-01-07`, retrieved 2026-10-31)
- Planned start: 2019-04-01 (anticipated) (ClinicalTrials.gov record NCT03794713, source copy `cardio:ctgov-nct03794713-2019-01-07`, retrieved 2026-10-31)
- Primary completion: 2020-09-01 (anticipated) (ClinicalTrials.gov record NCT03794713, source copy `cardio:ctgov-nct03794713-2019-01-07`, retrieved 2026-10-31)
- Completion: 2020-09-01 (anticipated) (ClinicalTrials.gov record NCT03794713, source copy `cardio:ctgov-nct03794713-2019-01-07`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03794713-2019-01-07`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Randomized, Two-arm, Open Label Study to evalUate the Effect of a Smart Phone-based Patient Support Tool On Patient AdheRence of Treatment in Stable Angina Patients Prescribed Beta-blockers in China (SUPPORT)
- Condition: Adrenergic Beta-Antagonists
- Condition: Stable Angina Pectoris
- Condition: Medication Adherence
- Condition: Mobile Applications
- Intervention (Device): Patient support tool
- Lead sponsor: Shenyang Northern Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry lists this organization as the lead sponsor: Shenyang Northern Hospital (`cardio:org-shenyang-northern-hospital`)

## Provenance

Content hash: 4f48a91e413a0f4b1600b4638df40b13dd7ed657a31cd9b2c228f3b6b29dafc7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
